Capricorn Partners seeks EUR 25m for industrial biotech VC fund
Belgian VC investor Capricorn Partners is open to more investor approaches for its new industrial biotech fund as it aims for a final close on EUR 25m by the end of next year, partner Rob van der Meij told Unquote.
More on Venture
Redalpine expands leadership team amid CHF 1bn-plus fundraise
Ex-Rocket Internet leader Bettina Curtze joins Swiss VC firm as partner and CFO
VC Profile: RTP Global gears up to deploy largest fund to date, remains bullish on breakout opportunities
Partner Gareth Jefferies discusses early-stage deployment plans and advantages of supporting startups throughout their lifecycle
Medicxi raises USD 400m to invest in single-focus life sciences companies
GP's fourth fund will deploy USD 10m-USD 20m tickets in narrow indications of unmet need; backed by pharma
Women in PE: Earth Capital's Bezuidenhoudt and Hockley on 2024 fund launch progress and co-investment pipeline
UK-based impact investorтs female leaders discuss deployment plans and the advantages of its syndicate co-investment strategy
Latest News
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Czech Republic-headquartered family office is targeting DACH and CEE region deals
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Ex-Rocket Internet leader Bettina Curtze joins Swiss VC firm as partner and CFO
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Estonia-registered VC could bolster LP base with fresh capital from funds-of-funds or pension funds